Metoclopramide Crescent Pharma

Metoclopramide, the active ingredient in Metoclopramide Crescent Pharma, is a dopamine antagonist presented as an oral tablet for oral use. It treats nausea, vomiting, gastroparesis, gastro‑oesophageal reflux disease and migraine‑associated nausea in adults.

GNH USA supplies Metoclopramide Crescent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide is used to manage conditions related to nausea, vomiting and delayed gastric emptying.

- Nausea and vomiting: alleviates acute and chemotherapy‑induced nausea and vomiting. - Gastroparesis: improves gastric emptying and reduces symptoms in diabetic or idiopathic gastroparesis. - Gastro‑oesophageal reflux disease (GERD): reduces reflux episodes by enhancing gastric motility. - Migraine‑associated nausea: lessens nausea accompanying migraine attacks.

Metoclopramide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: mild sedation or fatigue. - Restlessness: feeling of inner tension or agitation. - Diarrhea: loose stools or increased bowel movements. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Extrapyramidal symptoms: muscle rigidity, tremor, or dystonia. - Tardive dyskinesia: persistent involuntary movements with long‑term use. - Neuroleptic malignant syndrome: rare life‑threatening reaction with fever and muscle rigidity.

Before prescribing Metoclopramide, clinicians should consider several safety precautions. - Renal impairment: adjust use in patients with severe kidney dysfunction. - History of movement disorders: avoid in patients with Parkinson’s disease or prior extrapyramidal reactions. - Elderly patients: use cautiously due to increased risk of central nervous system effects. - Concomitant CNS depressants: monitor for enhanced sedation. - Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Metoclopramide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): may reduce antiemetic effect and increase extrapyramidal risk. - MAO inhibitors: can potentiate hypertensive reactions. - CYP2D6 substrates (e.g., codeine): may increase plasma levels of the substrate.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): enhanced sedation. - Digoxin: may increase digoxin serum concentrations. - Anticholinergic agents: may diminish pro‑kinetic effect.